Jinxin Fertility Group Limited (abbreviated as “JXR”) disclosed in its Monthly Return (Form FF301) for September 2026 that it executed a sizeable on-market share buy-back, moving a further 23.81 million ordinary shares into treasury during the month.

Key September Movements • Treasury Shares: Increased by 23.81 million to 30.48 million, representing about 1.13 % of the 2.71 billion total issued shares. • Outstanding Shares: Declined to 2.67 billion (from 2.70 billion), exactly matching the increase in treasury holdings; total issued share count remains unchanged at 2.71 billion. • Repurchase Activity: Between 1–23 September 2026, JXR completed 17 on-market repurchases at prices ranging from HK$2.10 to HK$2.23 per share, spending an estimated HK$51.34 million. All buy-backs were conducted under the mandate granted at the 25 June 2026 general meeting. • Pending Cancellations: An additional 92.47 million shares repurchased between 27 March and 25 August 2026 remain uncancelled and are classified as “shares repurchased for cancellation but not yet cancelled.” • Capital Structure: Authorised share capital stayed at 5.00 billion ordinary shares with a nominal value of USD 0.00001 each, unchanged at USD 50,000. No new shares were issued, and there were no option exercises, warrant conversions or other equity-linked issuances during the period. • Public Float: Management confirmed compliance with the Main Board’s minimum 25 % public float requirement as at 30 September 2026.

Implications September’s repurchase activity continues JXR’s capital management programme, indicating a preference for treasury accumulation ahead of formal cancellation. While the total share base remains stable, the rising treasury balance reduces the free-float and could affect liquidity until pending cancellations are completed.